<![CDATA[Triastek, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=37039>Sun, 26 Apr 2026 20:21:08 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results]]>https://www.newswire.co.kr/newsRead.php?no=1006551Thu, 27 Feb 2025 14:00:00 +0900<![CDATA[트라이어스텍, D23의 긍정적인 임상 결과 발표]]>https://www.newswire.co.kr/newsRead.php?no=1006552Thu, 27 Feb 2025 14:00:00 +0900<![CDATA[미국 식약청(FDA), MED™ 3D 프린터로 개발한 의약품에 대한 임상시험계획 신청 승인]]>https://www.newswire.co.kr/newsRead.php?no=918493Wed, 10 Feb 2021 17:29:00 +0900<![CDATA[MED™ 3D Printed Pharmaceutical Product Receives IND Clearance From the US FDA]]>https://www.newswire.co.kr/newsRead.php?no=918492Wed, 10 Feb 2021 17:28:51 +0900